Literature DB >> 8863851

Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist.

N Nishigaki1, M Negishi, A Ichikawa.   

Abstract

There are at least four subtypes of prostaglandin E (PGE) receptors. The EP1 and EP3 receptors are coupled to Ca2+ mobilization and the inhibition of adenylate cyclase, respectively, and the EP2 and EP4 receptors are coupled to the same signal transduction pathway, stimulation of adenylate cyclase. To identify the functional differences between EP2 and EP4 receptors, we examined agonist-induced desensitization of these two receptors using Chinese hamster ovary cells, which stably express these receptors. The EP4 receptor underwent short term agonist-induced desensitization, but no such desensitization was observed for the EP2 receptor. In contrast, the EP2 and EP4 receptors displayed similar patterns of down-regulation in response to prolonged exposure to PGE2. On the other hand, PGE2 is rapidly metabolized to 15-keto-PGE2 and, subsequently, to 13,14-dihydro-15-keto-PGE2. Thus, we compared the sensitivities of the two receptors to these two metabolites. The EP4 receptor markedly lost the response at the first metabolism, whereas the EP2 receptor gradually lost the response according to the degree of metabolism, having higher sensitivity to the first metabolite, 15-keto-PGE2, than the EP4 receptor. Therefore, the physiological significance of EP2 and EP4 may lie in their different sensitivities to agonist-induced short term desensitization and their differential susceptibilities to the metabolic inactivation of the agonist.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8863851

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  55 in total

Review 1.  Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes.

Authors:  S L Tilley; T M Coffman; B H Koller
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Identification of a region of the C-terminal domain involved in short-term desensitization of the prostaglandin EP4 receptor.

Authors:  M Bastepe; B Ashby
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

3.  EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway.

Authors:  Robert J George; Mark A Sturmoski; Shrikant Anant; Courtney W Houchen
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-01-03       Impact factor: 3.072

4.  Prostaglandin E2 Inhibits the Ability of Neutrophils to Kill Listeria monocytogenes.

Authors:  Michelle G Pitts; Sarah E F D'Orazio
Journal:  J Immunol       Date:  2019-05-06       Impact factor: 5.422

5.  Regulation of prostacyclin and prostaglandin E(2) receptor mediated responses in adult rat dorsal root ganglion cells, in vitro.

Authors:  D K Rowlands; C Kao; H Wise
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

6.  Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.

Authors:  Linda J Kay; Wilfred W Yeo; Peter T Peachell
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

Review 7.  Prostaglandin E2 receptor distribution and function in the gastrointestinal tract.

Authors:  I Dey; M Lejeune; K Chadee
Journal:  Br J Pharmacol       Date:  2006-10-02       Impact factor: 8.739

8.  Differential regulation of vascular tone and remodeling via stimulation of type 2 and type 6 adenylyl cyclases in the ductus arteriosus.

Authors:  Utako Yokoyama; Susumu Minamisawa; Ayako Katayama; Tong Tang; Sayaka Suzuki; Kousaku Iwatsubo; Shiho Iwasaki; Reiko Kurotani; Satoshi Okumura; Motohiko Sato; Shumpei Yokota; H Kirk Hammond; Yoshihiro Ishikawa
Journal:  Circ Res       Date:  2010-04-29       Impact factor: 17.367

9.  Prostaglandin E2 inhibits platelet-derived growth factor-stimulated cell proliferation through a prostaglandin E receptor EP2 subtype in rat hepatic stellate cells.

Authors:  Shigeki Koide; Yoshimasa Kobayashi; Yutaka Oki; Hirotoshi Nakamura
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

10.  The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis.

Authors:  Jennifer M McCoy; Joan R Wicks; Laurent P Audoly
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.